Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





Bioperfectus Demonstrates Novel Infectious Disease Testing Solutions at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: The STC-96A and STC-96A PLUS Real-Time PCR Systems were on display at AACC 2022 (Photo courtesy of Bioperfectus)
Image: The STC-96A and STC-96A PLUS Real-Time PCR Systems were on display at AACC 2022 (Photo courtesy of Bioperfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) is demonstrating its range of molecular diagnostic instruments and testing solutions for infectious diseases at the 2022 AACC Clinical Lab Expo, including its SAW-96 and SMPE-960 nucleic acid extraction systems, alongside the STC-96A and STC-96A PLUS real-time PCR systems.

The SAW-96 automated nucleic acid extraction workstation integrates cutting-edge mechanical, electronic, and software technologies. SAW-96 integrates sample loading, nucleic acid purification, and PCR setup functions in one instrument and has typical run duration of less than 70 minutes for 1-96 samples. Based on magnetic separation technology, SAW-96 provides high throughput automation combined with high performance. The SMPE-960 nucleic acid extraction system integrates cutting-edge mechanical, electronic and software technologies to enable automated extraction of nucleic acids from samples. Featuring a modular structure, the SMPE-960 can extract nucleic acids from 1-96 samples in three independently operating modules at the same time. Each module consists of 1-32 samples so that samples can be tested upon delivery.

The STC-96A and STC-96A PLUS real-time PCR systems offer stable performance and user-friendly design for molecular laboratories to identify viral and bacterial infections. In particular, the STC-96A Plus which is designed for real-time PCR analysis of gene expression and genetic variation allows two different PCR assays to be run on just one instrument with separate-controlled programs. Both the real-time PCR systems maintain a remarkable temperature uniformity of 0.1℃ across 96 wells, ensuring highly precise diagnostic results.

AT AACC 2022, Bioperfectus is also demonstrating its wide range of testing solutions for infectious diseases, including respiratory, sexually transmitted, vector-borne, gastrointestinal, and zoonotic. Among its respiratory infectious disease tests, Bioperfectus offers the COVID-19 Coronavirus real time PCR kit, COVID-19 Coronavirus (ORF1ab/N/E) real time PCR kit, Novel Corona Virus (SARS-CoV-2) Ag rapid test kit, Novel Corona Virus (SARS-CoV-2) IgM/IgG rapid test kit, Influenza A and B Viruses real time PCR kit, and COVID-19 Coronavirus and Influenza A/B Virus real time PCR kit. For sexually transmitted diseases, Bioperfectus offers the Human Papillomavirus Genotyping real time PCR kit, Neisseria Gonorrhoeae/Chlamydia Trachomatis/U. Urealyticum real time PCR kit and Chlamydia Trachomatis real time PCR kit, among others. In zoonotic diseases, Bioperfectus has recently launched the new Monkeypox Virus real time PCR kit based on real-time PCR technology. Specific primers and probes are designed based on F3L gene areas of the Monkeypox virus. In addition, the kit also contains a housekeeping gene (RNase P) as an internal control (IC) for specimen sampling and nucleic acid extraction.
 

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd. 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Pipet Controller
Stripettor Pro

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.